Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Theriva Biologics Has Received A Notice Of Allowance For A U.S. Patent Titled "ALKALINE PHOSPHATASE FORMULATIONS (FOR THE TREATMENT OF MICROBIOME-RELATED DISEASES)".

Author: Benzinga Newsdesk | September 03, 2025 02:58pm

https://patentcenter.uspto.gov/applications/18744950/ifw/docs

Posted In: TOVX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist